(Total Views: 370)
Posted On: 10/14/2020 7:04:25 AM
Post# of 36509
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Nugenerex Immuno-Oncology, of Miramar, Fla., a unit of Generex Biotechnology Corp., closed its previously-announced licensing and distribution agreement with Bintai Kinden Corp., of Malaysia, to develop and commercialize Ii-Key-SARS-CoV-2 coronavirus vaccine.
https://www.bioworld.com/articles/498894-othe...ct-13-2020
https://www.bioworld.com/articles/498894-othe...ct-13-2020
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)